Sven Olek is an inventor, industry expert, founder, and leader of Epiontis. Developed the patents forming the basis of Epiontis’s intellectual property. He conducted pre-and postdoctoral research at the Center for Molecular Biology and Biomedicine (ZMBH) of the University of Heidelberg, Germany, and the R.W. Johnson Pharmaceutical Research Institute, San Diego, California, USA. Sven received a BSc from the Imperial College of Science, Technology, and Medicine, London, and a Ph.D. in Biochemistry from the University of London.
Sign up to view 0 direct reports
Get started